Top Markets
Coin of the day
MabCure Inc. MabCure Inc.

MabCure Inc.

MBCI
주식 순위 #41405
MabCure Inc., a development stage company, engages in developing and... MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
주가
$0.0003
마지막 동기화: 2026-08-11
시가총액
$21.97K
변동 (1일)
0.00%
변동 (1년)
200.00%
국가
US
거래 MabCure Inc. (MBCI)

카테고리

MabCure Inc. (MBCI)의 EPS
2026 기준 EPS TTM: 0
MabCure Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
MabCure Inc.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.